American Century Companies’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-96,116
Closed -$582K 1472
2015
Q3
$582K Buy
96,116
+30,083
+46% +$369K ﹤0.01% 1191
2015
Q2
$1.04M Buy
+66,033
New +$802K ﹤0.01% 1142
2015
Q1
Sell
-36,076
Closed -$380K 1532
2014
Q4
$380K Buy
36,076
+3,887
+12% +$38K ﹤0.01% 1324
2014
Q3
$309K Buy
32,189
+354
+1% +$3.62K ﹤0.01% 1348
2014
Q2
$368K Buy
+31,835
New +$290K ﹤0.01% 1359

Other funds holding RPTP

American Century Companies's RPTP Position: Q4 2015 in Review

American Century Companies sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2015, closing a stake of 96,116 shares — an estimated $582K sold.

American Century Companies first reported a position in RPTP in Q2 2014 and held it in 5 quarters. The position peaked at $1.04M in Q2 2015. 108 funds tracked by Wall St. Rank hold RPTP as of Q4 2015.

  • American Century Companies reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • American Century Companies sold 96,116 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2015, an estimated $582K.
  • American Century Companies first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 5 quarters.
  • American Century Companies's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.04M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2015.

Based on American Century Companies's 13F filing for Q4 2015, filed 1 Feb 2016.